share_log

兴齐眼药(300573.SZ):获得溴芬酸钠滴眼液的药品注册证书

Shenyang Xingqi Pharmaceutical (300573.SZ) has obtained a pharmaceutical registration certificate for Bromfenac Sodium Eye Drops.

Gelonghui Finance ·  Jul 24 03:45

On July 24th, Gelunhui reported that Shenyang Xingqi Pharmaceutical (300573.SZ) announced that it has recently received the "Drug Registration Certificate" for Sodium Bromfenac Eye Drops issued by the National Drug Administration. The product is an eye drop whose main component is Sodium Bromfenac. The Sodium Bromfenac Eye Drops approved by the company are multi-dose products, clinically indicated for symptomatic treatment of inflammatory diseases in the external and anterior segments of the eye: blepharitis, conjunctivitis, scleritis (including superficial scleritis), and postoperative inflammation.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment